WHO ICTRP trial

Study on effect of topiroxostat administration on serum creatinine level in…

JPRN-UMIN000039120 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000039120
Public title Study on effect of topiroxostat administration on serum creatinine level in patients with hyperuricemia.
Scientific title Study on effect of topiroxostat administration on serum creatinine level in patients with hyperuricemia. - Study on effect of topiroxostat administration on serum creatinine level in patients with hyperuricemia.
Primary sponsor Koto Hospital
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Observational
Phase Not selected
Countries Japan
Conditions Hyperuricemia
Registration date Oct 1, 2020
Target size 100
Registry page center6.umin.ac.jp

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations